Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by palinc2000


T.TH

Voluntary shutdown of manufacturing?

.That would imply it seems  that they had not received a notice of...

6 days ago

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:New Press Release - Theratechnologies Provides Update on EGRIFTA SV® Supply

It seems almost surreal that they have recently restarted production and...

13 days ago

T.TH

RE:New Press Release - Theratechnologies Provides Update on EGRIFTA SV® Supply

Shhhhhhhhhhhhhhhhhhhhhhh PressRelease wrote: MONTREAL, Jan. 09, 2025 (GLOBE...

13 days ago

T.TH

RE:HIV lipodystrophy causes morbidity and mortality

Levesque was described as a marketing guru when  Dawn hired him Yet the...

December 21, 2024

T.TH

RE:RE:IONS drug was approved today as expected

https://seekingalpha.com/news/4388789-ionis-gets-fda-approval-for-tryngolza ...

December 19, 2024

T.TH

RE:IONS drug was approved today as expected

IONS still seems to be halted.... Did not see a PR yet

December 19, 2024

T.TH

RE:Article on Ionis and Olezarsen

We can easily access the important info on the frst page ,,,,PDUFA date less...

December 13, 2024

T.TH

RE:RE:They delivered on their follow-ups

My guess is the next step will be still a Phase 1 trial Part 4 .... Qwerty???

December 9, 2024

T.TH

RE:RE:New Press Release - Theratechnologies Announces Preliminary Tolerability and Efficacy Data from Phase 1b, Dose-Ranging Trial of Sudocetaxel Zendusortide in Patients with Advanced Ovarian Cancer

The best outcome would be  Out Licensing with an upfront payment  ...

December 9, 2024

T.TH

RE:New Press Release - Theratechnologies Announces Preliminary Tolerability and Efficacy Data from Phase 1b, Dose-Ranging Trial of Sudocetaxel Zendusortide in Patients with Advanced Ovarian Cancer

Very limited signs of efficacy...The real question is  Will they be able...

December 9, 2024

T.EDT

RE:RE:SMOKE SCREEN BUYER SELLER THIS MORNING

He does indeed  get a panic attack everytime the SP goes down...

December 6, 2024

T.EDT

Baxter restarts production

https://seekingalpha.com/news/4368508-baxter-restarts-dialysis-solutions...

December 5, 2024

T.TH

RE:New Press Release - Theratechnologies Announces Exclusive Licensing Agreement with Ionis to Commercialize Olezarsen and Donidalorsen in Canada

When will this be accretive if ever? As far as I know they dont have sales in...

December 4, 2024

T.TH

RE:RE:New Press Release - Theratechnologies Announces Resumed Production of EGRIFTA SV®

From the OCTOBER 10 CC transcripts Looking to 2025, I want to share the...

December 3, 2024

T.TH

RE:New Press Release - Theratechnologies Announces Resumed Production of EGRIFTA SV®

6 weeks later than forecast PressRelease wrote: MONTREAL, Dec. 03, 2024...

December 3, 2024

T.TH

Accordeon feature in the loan is very fitting indeed!!

THTX 's CEO is a great Violin player  Just missing a drummer for the...

December 2, 2024

T.TH

RE:New Press Release - Theratechnologies Submits Updated Tesamorelin F8 Formulation sBLA for FDA Review

In January 2024 they said that they would swifly adress the concerns of FDA ....

November 26, 2024

T.TH

Even better Nash news from Novo Nordisk

https://seekingalpha.com/news/4309561-novo-nordisksemaglutidephase-3-trialfor...

November 19, 2024

T.TH

Nash news from Viking

https://seekingalpha.com/news/4309209-viking-phase-2b-study-of-nash-candidate...

November 19, 2024

T.EDT

RE:New Press Release - Spectral Medical Announces Third Quarter Results and Provides Corporate Update

Now they have decided to be transparent Experienced significantly lower...

November 8, 2024